Have a personal or library account? Click to login
The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population Cover

The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

Balkan Journal of Medical Genetics
Volume 18 (2015): Issue 2 (December 2015)
By: J Plonis,  D Kalniete,  M Nakazawa-Miklasevica,  A Irmejs,  E Vjaters,  J Gardovskis and  E Miklasevics  
Open Access
|Jul 2016
DOI: https://doi.org/10.1515/bjmg-2015-0083 | Journal eISSN: 2199-5761
Journal RSS Feed
Language: English
Page range: 33 - 36
Published on: Jul 9, 2016
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Cancer,
Checkpoint kinase 2 () gene,
Chernobyl disaster liquidators,
del5395
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2016 J Plonis, D Kalniete, M Nakazawa-Miklasevica, A Irmejs, E Vjaters, J Gardovskis, E Miklasevics, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 18 (2015): Issue 2 (December 2015)Next article